|
The Future of Biopharma
|
|
|
| By
Eric S. Langer
|
|
|
|
What the industry's future holds and what needs to be done to get there.
|
|
|
|
A Look Ahead at BioPharma Manufacturing and Regulation
|
|
|
| By
Angie Drakulich
|
|
|
|
FDA talks about the changing scope of regulatory science.
|
|
|
|
Epigenetics Drives Pharma Innovation
|
|
|
| By
K. John Morrow, Jr., PhD
|
|
|
|
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.
|
|
|
|
Bioconjugates: The Adaptable Challenge
|
|
|
| By
Trishul Shah
|
|
|
|
Conjugation of a biologic to a carrier molecule can solve problems in solubility and stability, but introduces its own challenges.
|
|
|
|
Biologics: What Does the Future Hold?
|
|
|
|
Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.
|
|
|
|
Polishing Complex Therapeutic Proteins
|
|
|
| By
Min Lin, PhD
,
Nathalie Frau, PhD
,
Rene Faber, PhD
,
Ashley Hesslein, PhD
,
Jens H. Vogel, PhD
|
|
|
|
A new downstream purification platform using a salt-tolerant membrane adsorber.
|
|
|
